American Portfolios Advisors Vaxart, Inc. Transaction History

American Portfolios Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Mar 21, 2023	BUY	$4.29 - $6.64 $8,580 - $13,280	2,000 New	2,000 $10.1 Million
Q4 2021 Mar 21, 2023	BUY	$5.77 - $7.96 $12,117 - $16,716	2,100 New	2,100 $13.2 Million
Q3 2021 Mar 22, 2023	BUY	$6.67 - $9.8 $667 - $980	100 New	100 $795,000
Q2 2021 Mar 22, 2023	BUY	$5.06 - $10.78 $505 - $1,078	100 New	100 $749,000
Q1 2021 Mar 22, 2023	BUY	$5.64 - $23.33 $564 - $2,333	100 New	100 $605,000
Q4 2020 Mar 22, 2023	BUY	$3.5 - $7.98 $2,450 - $5,586	700 New	700 $4 Million
Q3 2020 Mar 22, 2023	BUY	$4.78 - $16.97 $1,434 - $5,091	300 New	300 $2 Million
Q2 2020 Mar 24, 2023	SELL	$1.68 - $8.85 $1,512 - $7,965	-900 Reduced 90.0%	100 $885,000
Q1 2020 Mar 24, 2023	BUY	$0.34 - $2.87 $340 - $2,870	1,000 New	1,000 $1.77 Million

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.